Atlas Arteria (ASX:ALX) - Aktienkurs, Nachrichten und Analyse

ALX Aktienübersicht

Atlas Arteria Limited besitzt, entwickelt und betreibt Mautstraßen.

ALX grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	3/6
Künftiges Wachstum	3/6
Vergangene Leistung	2/6
Finanzielle Gesundheit	3/6
Dividenden	4/6

Belohnungen

30.5% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 14.39% pro Jahr

Risikoanalyse

Die Dividende von 7.95% ist nicht ausreichend durch Gewinne oder Cashflows gedeckt.

Atlas Arteria Limited Wettbewerber

Transurban Group

ASX:TCL

AU$40.7b

Qube Holdings

ASX:QUB

AU$7.0b

Aurizon Holdings

ASX:AZJ

AU$6.4b

Dalrymple Bay Infrastructure

ASX:DBI

AU$1.6b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Atlas Arteria
Historische Aktienkurse
Aktueller Aktienkurs	AU$4.90
52-Wochen-Hoch	AU$6.07
52-Wochen-Tief	AU$4.63
Beta	0.78
11 Monat Veränderung	-3.73%
3 Monate Veränderung	-4.11%
1 Jahr Veränderung	-11.39%
33 Jahre Veränderung	-22.83%
5 Jahre Veränderung	-38.75%
Veränderung seit IPO	696.75%

Aktuelle Nachrichten und Updates

Recent updates

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Apr 07

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Dec 22

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Aug 10

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

May 31

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Apr 14

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Mar 03

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Feb 27

Atlas Arteria (ASX:ALX) Has Compensated Shareholders With A Respectable 78% Return On Their Investment

Jan 31

Atlas Arteria Limited (ASX:ALX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Dec 27

How Many Atlas Arteria Limited (ASX:ALX) Shares Do Institutions Own?

Dec 06

Is There Now An Opportunity In Atlas Arteria Limited (ASX:ALX)?

Nov 19

Atlas Arteria (ASX:ALX) Has Gifted Shareholders With A Fantastic 142% Total Return On Their Investment

Jul 30

Aktionärsrenditen

	ALX	AU Infrastructure	AU Markt
7D	3.4%	-1.4%	0.4%
1Y	-11.4%	2.5%	16.4%

Rendite im Vergleich zur Industrie: ALX unter dem Niveau der Branche Australian Infrastructure , die im vergangenen Jahr eine Rendite von -9.6% erzielte.

Rendite vs. Markt: ALX hinter dem Markt Australian zurück, der im vergangenen Jahr eine Rendite von 9.6 erzielte.

Preisvolatilität

Is ALX's price volatile compared to industry and market?
ALX volatility
ALX Average Weekly Movement	2.9%
Infrastructure Industry Average Movement	2.5%
Market Average Movement	8.8%
10% most volatile stocks in AU Market	16.7%
10% least volatile stocks in AU Market	3.6%

Stabiler Aktienkurs: ALX hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: ALXDie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2009	n/a	Hugh Wehby	www.atlasarteria.com

Atlas Arteria Limited besitzt, entwickelt und betreibt Mautstraßen. Das Unternehmen hält 31,14 % der Anteile an der APRR und der A79 sowie 31,17 % der Anteile an der ADELAC in Frankreich; 100 % der Anteile am Warnowtunnel in Rostock, Deutschland; 66,67 % der Anteile am Chicago Skyway in Chicago und 100 % der Anteile am Dulles Greenway in Virginia, Vereinigte Staaten. Das Unternehmen war früher unter dem Namen Macquarie Atlas Roads Limited bekannt und änderte im Mai 2018 seinen Namen in Atlas Arteria Limited.

Atlas Arteria Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Atlas Arteria im Vergleich zum Marktanteil des Unternehmens?
ALX grundlegende Statistiken
Marktanteil	AU$7.11b
Gewinn(TTM)	AU$300.20m
Umsatz(TTM)	AU$140.10m

23.7x

Kurs-Gewinn-Verhältnis

50.7x

Kurs-Umsatz-Verhältnis

Ist ALX zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
ALX Gewinn- und Verlustrechnung (TTM)
Einnahmen	AU$140.10m
Kosten der Einnahmen	AU$47.80m
Bruttogewinn	AU$92.30m
Sonstige Ausgaben	-AU$207.90m
Umsatz	AU$300.20m

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

Feb 27, 2025

Gewinn per Aktie (EPS)	0.21
Bruttomarge	65.88%
Nettogewinnspanne	214.28%
Schulden/Eigenkapital-Verhältnis	27.2%

Wie hat sich ALX auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

8.2%

Aktuelle Dividendenrendite

194%

Ausschüttungsquote

ALX Aktienübersicht

Belohnungen

Risikoanalyse

Atlas Arteria Limited Wettbewerber

ASX:TCL

AU$40.7b

ASX:QUB

AU$7.0b

ASX:AZJ

AU$6.4b

ASX:DBI

AU$1.6b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Recent updates

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Atlas Arteria Limited Appoints Hugh Wehby as Managing Director

Atlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025

Final dividend of AU$0.20 announced

Atlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024

Atlas Arteria Limited, Annual General Meeting, May 15, 2024

Atlas Arteria Limited, Annual General Meeting, May 16, 2024

Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Consensus EPS estimates fall by 11%

First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)

Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023

Atlas Arteria Limited to Report First Half, 2024 Results on Aug 29, 2024

Atlas Arteria Limited Appoints Ken Daley as Director

Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023

Consensus EPS estimates fall by 15%

Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)

Insufficient new directors

Atlas Arteria Limited Announces Board Changes

Atlas Arteria Limited (ASX:ALX) completed the acquisition of 66.67% stake in Skyway Concession Company, LLC from CPP Investments and OMERS Infrastructure.

Now 20% undervalued after recent price drop

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2023

Consensus revenue estimates increase by 10%

Atlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023

Price target decreased to AU$6.96

Investor sentiment deteriorated over the past week

Atlas Arteria Limited Provides Distribution Guidance for the Year 2023

Atlas Arteria Limited (ASX:ALX) entered into an agreement to acquire a 66.67% stake in Skyway Concession Company, LLC for $2 billion.

Consensus EPS estimates fall by 14%

First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)

Atlas Arteria Limited Provides Dividend Guidance for the First Half of 2022

Price target increased to AU$7.40

Investor sentiment improved over the past week

Atlas Arteria Limited Announces Executive Changes

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Independent Non-Executive Director recently bought AU$76k worth of stock

Full year 2021 earnings: EPS and revenues miss analyst expectations

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Insider recently bought AU$67k worth of stock

First half 2021 earnings released: EPS AU$0.074 (vs AU$0.14 loss in 1H 2020)

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

Price target decreased to AU$6.21

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Independent Chairman of the Board recently bought AU$100k worth of stock

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Full year 2020 earnings released: AU$0.061 loss per share (vs AU$0.024 profit in FY 2019)

Atlas Arteria Limited Announces Board Changes

New 90-day low: AU$5.97

Atlas Arteria Limited to Report Fiscal Year 2020 Results on Feb 25, 2021

Erträge & Einnahmen